Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia

Cancer

Volumn 97, Issue 8, 2003, Pages 1914-1919

  Ibrahim, Sherif ^a   Jilani, Iman ^b   O'Brien, Susan ^b   Rogers, Anna ^b   Manshouri, Taghi ^b   Giles, Francis ^b   Faderl, Stefan ^b   Thomas, Deborah ^b   Kantarjian, Hagop ^b   Keating, Michael ^b   Albitar, Maher ^b  

^a NEW YORK UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

CD31; CD38; Chronic lymphocytic leukemia; Prognosis; Survival

Indexed keywords

CD19 ANTIGEN; CD31 ANTIGEN; CD38 ANTIGEN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADP-RIBOSYL CYCLASE; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD31; ANTIGENS, CD38; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0037446136     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11264     Document Type: Article

References (21)

1. Jackson DE, Gully LM, Henshall TL, Mardell CE, Marcardle PJ. Platelet endothelial cell adhesion molecule-1 (PECAM1/CD31) is associated with a naïve B-cell phenotype in human tonsils. Tissue Antigens. 2000;56:105-116.
2. McKenney J, Weiss SW, Folpe AL, Andrew L. CD31 expression in intratumoral macrophages: a potential diagnostic pitfall. Am J Surg Pathol. 2001;25:1167-1173.
3. Newman PJ. Perspectives series: cell adhesion in vascular biology. J Clin Invest. 1997;99:3-8.
4. Newman PJ, Berndt MC, Gorski J, et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science. 1990;247:1219-1222.
5. Stockinger H, Gadd SJ, Eher R, et al. Molecular characterization and functional analysis of the leukocyte surface protein CD31. J Immunol. 1990;145:3889-3897.
6. Simmons DL, Walker C, Power C, Pigott R. Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J Exp Med. 1990;171:2147-2152.
7. Deaglio S, Morra M, Mallone R, et al. Human CD38 (ADPribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol. 1997;160:395-402.
8. Vallario A, Chilosi M, Adami F, et al. Human myeloma cells express the CD38 ligand CD31. Br J Haematol. 1999;105:441-444.
9. Schattner EJ, Mascarehas J, Reyfman I, et al. Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity. Blood. 1998; 91:2689-2697.
10. Clodi K, Asgary Z, Zhao S, et al. Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells. Br J Haematol. 1998; 103:270-275.
11. Zupo S, Isnardi L, Megna M, et al. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood. 1996;88:1365-1374.
12. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848-1854.
13. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999:94;1840-1847.
14. Damle R, Wasali T, Allen S, et al. Updated data on V gene mutation status and CD38 expression in B-CLL. Blood. 2000; 95:2456-2457.
15. Ibrahim S, Keating M, Do K, et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood. 2001;98:181-186.
16. Jelinek DF, Tschumper RC, Geyer SM, et al. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukemia. Br J Hematol. 2001;115:845-861.
17. Muller WA, Weigl SA, Deng X, Philips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med. 1993;178:449-460.
18. Albelda SM, Oliver PD, Romer LH, Buck CA. EndoCAM: a novel endothelial cell-cell adhesion molecule. J Cell Biol. 1990;110:1227-1237.
19. Goldberger A, Middleton KA, Newman PJ. Changes in expression of the cell adhesion molecule PECAM-1 (CD31) during differentiation of human leukemic cell lines. Tissue Antigens. 1994;44:285-293.
20. Watt SM, Williamson J, Genevier H, et al. The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and Blymphoid cell phenotypes. Blood. 1993;82:2649-2663.
21. Tucillo F, Bonelli P, Tassone P, et al. CD31 expression in B cell chronic lymphocytic leukemia. Tissue Antigens. 2000;55(Suppl 1):25.